Q2 2025 Management View CEO Kim Kelderman highlighted 9% organic revenue growth for the quarter, driven by strong performance in biopharma end markets, particularly large pharma, which benefited GMP ...

Bio-Techne Corp (TECH) reports 9% organic revenue growth, improved margins, and strategic geographic expansion despite ...

Leeford is shaping the future of healthcare through cutting-edge formulations and a commitment to global quality standards.

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...

Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...

High Tide is the largest cannabis retailer in Canada. President and CEO Raj Grover joins us to discuss its recent move into ...

Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO and Ampersand’s deep experience in CDMO investing to support Avid’s next stage of rapid ...